戻る Agenda
AMPLEXOR Innovation Theater: The Great Regulatory Catch-up: Lessons From Big Pharma as Medical Device Manufacturers Succumb to New Reporting Rigor
Session Chair(s)
Amplexor Life Sciences
Slovenia
Medical device manufacturers rarely like to be compared to their life sciences industry cousins in pharmaceuticals. Yet they could learn a thing or two from the sector which, for the last 14 years, has been subject to the sorts of rigorous electronic reporting standards device producers will now be subjected to. Today, the 2 affiliated industries have a great deal more in common than they realise, and to ignore the parallels and start from scratch with MDR and other standards now being imposed by international authorities, will double the work companies face. AMPLEXOR’s David Gwyn charts the similarities and distils some takeaway best practices.
Speaker(s)
David Gwyn, MBA
fme Life Sciences, United States
Vice President, Strategy and Solutions